Clinical Trial Update: Pars Plana Vitrectomy for Diabetic Fibrovascular Proliferation With and Without Internal Limiting Membrane Peeling [Phase 1, Phase 2]

View source ↗

Summary

This entry describes an ongoing Phase 1/Phase 2 study of pars plana vitrectomy with and without inner limiting membrane peeling for active fibrovascular prolife…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Proliferative Diabetic Retinopathy

Snippet

Sponsor: National Taiwan University Hospital | Conditions: Patients With Proliferative Diabetic Retinopathy Who Have Active Fibrovascular Proliferation | Phase 1, Phase 2 | Status: UNKNOWN